Hints and tips:
Showing results for ENDO PHARMACEUTIALS INC.
Related Special Reports
...Ken Endo, the chief executive of Sompo’s nursing care and seniors business, says “the industry is 100 per cent dependent on people, yet there has been no system in place to deepen your expertise” — a fact...
...“In Japan, vendors supply about 70 per cent of the IT engineers and the ratio of IT specialists inside the banks is extremely low,” said Endo....
...Its case against Endo, Teva, and Allergan is currently being tried in state court. The settlement payments to New York will begin this summer and continue over the next 17 years....
...In addition to J&J, the complaint named Purdue Pharma and the members of the Sackler family that own it, Mallinckrodt, Endo, and Teva among others....
...“We plan to continue investigating the validity of the insurance policies,” Endo said....
...This will increase the merits of filing patent infringement suits, according to lawyer Makoto Endo....
.... ©2019 Nikkei Inc. All rights reserved....
...“What we want from companies, and what investors expect, is effective governance,” said Mr Endo....
...This month, Endo announced it had settled in principle by agreeing to pay $10m and up to $1m in products to two plaintiff counties in Ohio....
...Endo International, which settled these cases for about $10m, was down 2.4 per cent to $4.76, and Mallinckrodt, which settled the two cases for about $30m, fell 3 per cent to $2.66....
...Japan Inc: corporate governance battle The stage is set for a rare hostile takeover drama in Japan as Yoshiaki Murakami (below) –– the country’s most notorious shareholder activist –– sets his eyes on a...
...It has requested that one opioid — Opana ER, made by Endo Pharmaceuticals — be removed from the market because of patterns of abuse, but also approved Dsuvia, by AcelRx Pharmaceuticals, another fast-acting...
...The carmaker “had literally no governance structure”, Koji Endo, head of the equity research department at SBI Securities, said at the time of the arrest in November....
...A version of this article was first published by the Nikkei Asian Review on May 5 2019. ©2019 Nikkei Inc. All rights reserved....
...Among the most commonly named defendants are drugmakers such as Purdue Pharmaceuticals, which is privately owned, Johnson & Johnson, Allergan, Mallinckrodt, Endo and Teva; distributors such as McKesson,...
...The new system would probably be funded by the pharmaceutical groups that manufacture opioid medicines — such as Perdue Pharma, Endo and Depomed — which have been sharply criticised for fuelling the crisis...
...Shares in Endo rose 15.5 per cent to $23.39 in New York after the company said Rajiv De Silva, who has served at the helm since March 2014 and helped grow Endo’s overseas presence, was stepping down....
...Nikkei staff writer Jun Endo contributed to this report. A version of this article was first published by the Nikkei Asian Review on January 23. ©2018 Nikkei Inc. All rights reserved....
...Some investors argue that Endo is similarly overly-reliant on debt-fuelled deal making and high drug prices....
...Japanese government officials pushed back against Donald Trump’s criticism of Toyota as the attack on the country’s most powerful corporate name sent shockwaves across Japan Inc....
...Fears surrounding Valeant reverberated through to other junk-rated healthcare companies, including Endo International and Mallinckrodt....
...The three companies — Valeant, Endo and Mallinckrodt — have levered up over the past two years in aggressive expansions....
...Valeant, for instance, ended up going toe to toe with another roll-up, Endo, in the bidding war for Salix. But most platform companies ultimately unwind because they depend excessively on momentum....
...Why, then, is the market so tepid on Endo’s $8bn cash and stock purchase of Par, a generics company? After Monday’s announcement, Endo’s shares fell 5 per cent....
...A number of listed pharmaceutical companies, including Valeant, Endo and Mallinckrodt, have made it their business to buy up branded off-patent remedies and pump up prices....
International Edition